Increasing Participation of Women in Early Phase Clinical Trials Approved by the FDA
Bibliographic Data
| ID | 15312842 |
|---|---|
| Authors | Ellen Pinnow (0000-0002-9183-4662, United States Food and Drug Administration, corresponding author), Pellavi Sharma (United States Food and Drug Administration), Ameeta Parekh (0000-0002-1910-2328, United States Food and Drug Administration), Natalie Gevorkian (0009-0006-1054-1048, United States Food and Drug Administration), Kathleen Uhl (United States Food and Drug Administration) |
| Year | 2009 |
| Volume | 19 |
| Issue | 2 |
| Pages | 89-93 |
| Publication date | 2009-03-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Women s Health Issues (JOURNAL) |
| Journal identifiers | ISSN: 1049-3867 • E-ISSN: 1878-4321 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.whi.2008.09.009 |
| PMID | 19272558 |
| OpenAlex | W2096049819 |
| Language | EN |
| Citations received | 5 |
| References cited | 5 |
Adverse effect · Alternative medicine · Clinical trial · Family medicine · Institutional review board · Pathology · Physical therapy · Tolerability · Ethics in Clinical Research · Health Systems, Economic Evaluations, Quality of Life · Medicine · Pharmaceutical industry and healthcare · Internal Medicine · Surgery
Over-represented as volunteers, under-represented as patients
Disadvantaged, outnumbered, and discouraged
A genderful research world
Policy Implications of a New National Institutes of Health Agenda for Women’s Health Research, 2010–2020
Challenging Assumptions About Minority Participation in US Clinical Research
| Citations per year | 0.33 |
|---|---|
| Citation span | 2011 - 2026 (16) |
| Highly cited | No |